Automated Nucleic Acid Assays With Random Access Parameter Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing analytical systems are limited to performing molecular assays in batch mode, requiring separate processing of IVD and LDT assays without the ability to perform them simultaneously or in random order, necessitating reagent and consumable changes between assay types.

Innovation Solution

An automated analyzer capable of performing multiple nucleic acid amplification assays with system-defined and user-defined parameters, allowing simultaneous execution of IVD and LDT assays on the same or different samples using shared modules and random access mode, with features like magnetic solid supports, fluid transfer, and real-time detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If batch mode processing is used for molecular assays, then assay completion is ensured, but system downtime increases and productivity decreases

Engineering Contradiction:
Improveassay completionVSAvoidthroughput
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The system dynamically switches between batch mode and random access mode based on assay requirements. The automated analyzer can pause batch processing to accommodate random access requests, and vice versa, allowing flexible adaptation to different operational scenarios without compromising either reliability or productivity

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system implements periodic reagent replacement cycles within batch mode processing. Reagents are automatically replaced at predetermined intervals during batch processing, enabling continuous operation without complete system downtime while maintaining assay completion reliability

Inventive Principle:
Principle #19Periodic action

2Reliability

If separate processing of IVD and LDT assays is performed, then assay specificity is maintained, but operational complexity increases and time loss occurs

Engineering Contradiction:
Improveassay specificityVSAvoidreagent change time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The automated analyzer is designed with universal reagent storage and delivery systems that can accommodate both IVD and LDT assay requirements. The system uses universal reaction vessels and detection mechanisms that work with different assay types, eliminating the need for separate processing while maintaining assay specificity through software-controlled parameter differentiation

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system introduces an automated reagent management system as an intermediary between reagent storage and assay processing. This intermediary automatically tracks reagent types, volumes, and compatibility, enabling seamless transitions between IVD and LDT assays without manual intervention or time-consuming reagent changes

Inventive Principle:
Principle #24Intermediary (Mediator)

3Adaptability or versatility

If random access mode is implemented, then operational flexibility increases and productivity improves, but system complexity increases

Engineering Contradiction:
Improveoperational flexibilityVSAvoidsystem complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The system segments control functions into modular software components that manage different access modes independently. The random access controller, batch mode controller, reagent management module, and detection module operate as separate but coordinated units, reducing overall system complexity through functional segmentation while maintaining operational flexibility

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The automated analyzer implements self-service through automated sample tracking, reagent management, and assay parameter selection. The system automatically identifies samples, selects appropriate assays based on pre-programmed protocols, and adjusts processing parameters without user intervention, reducing the complexity burden on operators while maintaining high adaptability

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables flexible and efficient performance of multiple nucleic acid amplification assays with reduced downtime, supporting both IVD and LDT assays concurrently and in any order, enhancing operational flexibility and throughput.

Implementation Method 1

The automated system may include one or more wash stations configured to expose a first sample to reagents and conditions sufficient to immobilize a first analyte on a first magnetic solid support

Methodology Applied
Scientific EffectMagnetic field interaction: Magnetic Field

Implementation Method 2

PCR employs thermal cycling, which consists of repeated cycles of heating and cooling of a reaction mixture

Methodology Applied
Scientific EffectThermal cycling: Heating

Implementation Method 3

The growth of the amplicon may be detected using signal detecting devices (e.g., fluorescence detection devices) that measure signal emissions (e.g., level of fluorescence at a predetermined wavelength or range of wavelengths, etc.) indicative of the amplicon

Methodology Applied
Scientific EffectFluorescence detection: Fluorescence

Data Source

PatentEP4722729A2Analytical systems and methods for nucleic acid amplification using sample assigning parameters
Publication Date: 2026.04.08 GEN PROBE INC
  • EP4722729A2 patent drawingFigure 1A
  • EP4722729A2 patent drawingFigure 1B
  • EP4722729A2 patent drawingFigure 2A

AI summary

Systems and methods for performing a plurality of nucleic acid amplification assays in an automated analyzer. A first nucleic acid amplification assay of the plurality is performed in accordance with a first set of assay parameters which consist of system-defined parameters. And a second nucleic acid amplification assay of the plurality is performed in accordance with a second set of assay parameters which includes one or more user-defined parameters.